meglumine has been researched along with Depression, Endogenous in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bagot, RC; Berton, O; Cahill, ME; Dietz, DM; Fallon, B; Feng, J; Ferguson, D; Harrigan, E; Joshi, T; Ku, SM; Mazei-Robison, M; Nestler, EJ; Robison, AJ; Vialou, V; Winstanley, CA | 1 |
Faizullin, RM; Kalugina, AV; Malkin, MP; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, IA | 1 |
Pravdin, EV; Uzlova, TV; VolchegorskiÄ, IA | 1 |
Adams, JB; Costa, J; Cutler, NR; Greiner, M; Pande, AC; Pierce, MW; Pyke, RE; Schweizer, E; Wilcox, CS; Wisselink, PG | 1 |
2 trial(s) available for meglumine and Depression, Endogenous
Article | Year |
---|---|
[Effect of 3-oxypyridine and succinic acid derivatives on affective status in recrudescence of inflammatory diseases of uterus and its appendages].
Topics: Adnexa Uteri; Adolescent; Adult; Antioxidants; Brain; Depressive Disorder; Female; Genital Diseases, Female; Humans; Inflammation; Interleukin-1beta; Meglumine; Middle Aged; Phagocytosis; Picolines; Prospective Studies; Pyridines; Recurrence; Succinates; Succinic Acid; Tumor Necrosis Factor-alpha; Uterus | 2012 |
A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Colonic Diseases, Functional; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Indoles; Male; Meglumine; Panic Disorder; Personality Inventory; Phobic Disorders; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Somatoform Disorders; Treatment Outcome | 1995 |
2 other study(ies) available for meglumine and Depression, Endogenous
Article | Year |
---|---|
Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of ΔFosB.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain Mapping; Cholecystokinin; Chronic Disease; Depressive Disorder; Indoles; Limbic System; Male; Meglumine; Mice; Mice, Inbred C57BL; Neural Pathways; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Receptor, Cholecystokinin B; Social Dominance; Stress, Psychological | 2014 |
[Antidepressant effect of 3-oxypyridine and succinic acid derivatives (experimental study)].
Topics: Animals; Behavior, Animal; Depressive Disorder; Disease Models, Animal; Female; Male; Meglumine; Picolines; Psychotropic Drugs; Pyridines; Rats; Succinates; Succinic Acid | 2015 |